BridgeBio Pharma CEO Neil Kumar reports sale of $4.28 million in common shares
BBIO•BridgeBio Pharma CEO and director Neil Kumar sold 54,980 common shares on Nov. 18-19, 2026, for reported weighted-average prices ranging from $76.9915 to $79.293 per share.
1. Share sales
Kumar sold 34,980 shares directly, leaving him with 243,327 shares held directly. The Kumar Haldea Family Irrevocable Trust sold 20,000 shares, reducing its holdings to 475,686 shares.




